pBK1311-AAV-EFSNC-dSaCas9-NIPP1(143-224)
(Plasmid
#223156)
-
PurposeExpression of truncated NIPP1 with dSaCas9 and empty gRNA scaffold
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 223156 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneUnknown
-
Vector typeMammalian Expression, AAV, CRISPR
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameNIPP1
-
Alt namePPP1R8
-
SpeciesH. sapiens (human)
-
MutationEncodes aa 143-224
-
Entrez GenePPP1R8 (a.k.a. ARD-1, ARD1, NIPP-1, NIPP1, PRO2047)
- Promoter EF1a
-
Tag
/ Fusion Protein
- 3xFLAG (N terminal on backbone)
Cloning Information
- Cloning method Unknown
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2023.04.14.536951 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pBK1311-AAV-EFSNC-dSaCas9-NIPP1(143-224) was a gift from Boris Kantor (Addgene plasmid # 223156 ; http://n2t.net/addgene:223156 ; RRID:Addgene_223156) -
For your References section:
All-in-one AAV-delivered epigenome-editing platform: proof-of-concept and therapeutic implications for neurodegenerative disorders. Kantor B, Odonovan B, Rittiner J, Hodgson D, Lindner N, Guerrero S, Dong W, Zhang A, Chiba-Falek O. bioRxiv [Preprint]. 2024 May 19:2023.04.14.536951. doi: 10.1101/2023.04.14.536951. 10.1101/2023.04.14.536951 PubMed 38798630